- Abu Dhabi Will Aid Debt-Fraught Dubai 'Case by Case'
- Banks With The Biggest Exposure to The UAE
- Dubai's Debt Woes Signal New Era for Creditors
- Next Week: Cash In Now Or Wait For A Santa Rally?
- Dubai Stock Selloff May Bring Buying Opportunity
- Longer Lines, Fuller Carts This Black Friday
- Big US Banks May Be Forced to Raise Capital: Bove
- Bank of America Amends Pay for Senior Executives
- Tiger Woods Out of Hospital After Accident
- U.S. Stocks Fall on Dubai Worries
- Black Friday at Best Buy
- Strategists on Dubai: Avoid 'Rash Moves' Now
- Longer Lines, Fuller Carts This Black Friday
- Dubai Stock Market Fear Has 'Legs': Dennis Gartman
- Obama's Emission Reduction Pledge Paints Future for Autos
- Is Super Bowl Halftime Act Too Old?
- Surprising Options Trades in TiVo Shares
- EA Sports Hopes to Pump Up Sales Through Pop-Up Locations
- Text-a-Tip programs allow tipsters to help police
- Police: Blaze in NY Walmart's Xmas-tree section
- Administration plans new efforts on foreclosures
- Leaders say momentum building on climate change
- Cars burned, windows broken at trade protest
- Police tap into ‘text-a-tip’ programs
- Is Dubai Abu Dhabi's case of too big to fail?
- Bernanke makes case for strong Fed role on banks
- GM says production at Ohio plant to end Jan. 29
Panel likes blood thinner — for some patients
Text Size 
There’s life-saving potential, but don’t give to stroke patients, experts say
SILVER SPRING, Md. - A panel of government health experts says a highly anticipated Eli Lilly blood thinner has lifesaving potential, but should not be given to patients with a history of stroke.
Expert advisers to the Food and Drug Administration say the drug's labeling should alert doctors that stroke patients face a high risk of suffering another stroke if they take the medication.
The panel will vote later today on whether to recommend approval of the experimental drug. The FDA is not required to follow the group's recommendations, though it usually does.
Indianapolis-based Eli Lilly has asked the Food and Drug Administration to approve its highly anticipated drug to prevent dangerous blood clots in patients with acute heart problems.
Click for related content
Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Print
Email
- These four sectors will be the next to lead the market.
- Zhu Zhu Pets are this year's must-have toy, fetching $40 or more on eBay.
- From the why-didn’t-I-think-of-that file, we present Jason Sadler, a man whose job is wearing T-shirts.
- It may be the most unusual guide to business you'll read.
- Shopping for a gadget hound? The choices can be baffling. Here are a few that should be a hit.
- "The Who" will be the halftime act for Super Bowl XLIV on Feb. 7 in Miami. Is the NFL behind the times?
Data is a real-time snapshot *Data is delayed at least 15 minutes